Laurion Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-61,458	Closed	-$55.8K	–	369
2025 Q2	$55.8K	Buy	+61,458	New	+$36.5K	0.01%	370
2024 Q1	–	Sell	-433,748	Closed	-$473K	–	607
2023 Q4	$473K	Sell	433,748 -702,723	-62%	-$770K	0.02%	395
2023 Q3	$1.34M	Sell	1,136,471 -829,776	-42%	-$1.13M	0.04%	358
2023 Q2	$2.77M	Sell	1,966,247 -411,693	-17%	-$569K	0.12%	298
2023 Q1	$3.57M	Hold	2,377,940	–	–	0.16%	252
2022 Q4	$2.78M	Hold	2,377,940	–	–	0.08%	295
2022 Q3	$2.69M	Sell	2,377,940 -44,427	-2%	-$65.2K	0.07%	302
2022 Q2	$3.83M	Buy	+2,422,367	New	+$3.19M	0.16%	190
2020 Q3	–	Sell	-12,476	Closed	-$11K	–	1019
2020 Q2	$11K	Buy	+12,476	New	+$11K	﹤0.01%	858
2018 Q2	–	Sell	-200,458	Closed	-$472K	–	1466
2018 Q1	$472K	Buy	+200,458	New	+$470K	0.01%	1022